Antimicrobial Stewardship in Dentistry

Clinical overview

Antimicrobial Stewardship in Dentistry is a clinically relevant subject within Pharmacology. This DentaCalc reference is intended for dental professionals as a structured aid to assessment, interpretation, treatment planning, monitoring and documentation. It does not replace a complete history and examination, current national or specialty guidance, product information, local pathways or referral when complexity exceeds the clinician’s competence or available facilities.

The purpose of a clinical reference is to make reasoning more explicit. Before collecting additional measurements or investigations, define the question that the information is intended to answer. The significance of a finding depends on the diagnosis, disease activity, previous treatment, medical and dental history, patient priorities and the reliability of the method used to obtain it.

History and assessment

Assessment of antimicrobial stewardship in dentistry should begin with the presenting concern and relevant medical, dental and social history. Record onset, duration, progression, previous episodes or treatment, medicines, allergies and systemic factors that may change risk or management. Tobacco and alcohol exposure, diet, oral hygiene, parafunction, attendance pattern, anxiety, communication needs and previous dental experience should be considered where relevant.

Assessment should combine the relevant history, examination, reproducible measurements, appropriate investigations, diagnosis, risk factors and the patient’s priorities. Use a consistent examination sequence and terminology. For numerical measurements, record the site, landmark, instrument, units and scoring convention. Investigations should have a defined clinical purpose and be proportionate to expected benefit. Imaging must be justified and the complete image interpreted, not merely the region that prompted the exposure.

Diagnosis and interpretation

The working diagnosis should be supported by the recorded findings. If uncertainty remains, document a differential diagnosis and identify what additional observation, test, imaging or specialist opinion would help resolve it. Avoid allowing a single score, threshold or image finding to substitute for the wider diagnosis and patient context.

Serial measurements are most useful when methods remain sufficiently consistent. Differences in examiner technique, calibration, landmarks, radiographic geometry, scoring definitions or denominator selection can create apparent change that is methodological rather than biological. Record source data as well as derived values so that calculations and interpretation can be checked later.

Management principles

Management should follow from the diagnosis, urgency, prognosis and patient’s informed priorities. Address pain, active disease and modifiable risk factors before complex irreversible treatment where appropriate. Explain reasonable alternatives, including monitoring, staged care or referral when relevant, and discuss material risks, expected benefits, uncertainty, maintenance requirements and consequences of no treatment.

Where treatment is provided, sequence care so that response to disease-control measures can be reassessed before later stages when that response materially affects prognosis. Follow current guidance and manufacturer instructions for medicines, devices and materials. Seek advice or refer when the diagnosis, technical difficulty, medical risk or required facilities lie outside the operator’s competence.

Monitoring and review

A review plan should state what will be reassessed, when it will be reassessed and what finding would change management. Depending on the topic, outcomes may include symptoms, disease activity, clinical measurements, lesion appearance, radiographic findings, restoration or prosthesis integrity, function, patient-reported experience and adherence to preventive measures.

Unexpected deterioration should prompt reconsideration of the diagnosis, risk factors, adherence, technical factors and measurement method rather than automatic repetition of the same intervention. Recall and review should be individualised according to risk, current guidance and the clinical problem.

Communication, consent and documentation

Connect the diagnosis to the available options in language appropriate to the patient. Discuss important uncertainty and material risks without implying false precision. Shared decision-making is strongest when the record shows the professional recommendation, reasonable alternatives and the patient’s own priorities and decision.

Records should allow another appropriately qualified professional to understand what was found, how it was assessed, what conclusion was reached and why the chosen plan was reasonable. Include relevant measurements and units, imaging findings, diagnosis or differential diagnosis, risk modifiers, alternatives, consent, advice, safety-netting and intended review.

Common pitfalls

• Using an isolated score or threshold without the wider clinical context.
• Comparing serial measurements obtained with materially different methods.
• Ordering investigations without a defined question or failing to interpret the complete result.
• Failing to document diagnostic uncertainty, alternatives, consent or the review plan.
• Using general educational material instead of current authoritative guidance for a specific clinical action.

Safety and limitations

Dental evidence, professional standards and product information change over time and may differ between jurisdictions. For prescribing, invasive procedures, sedation, radiography, anticoagulant management, safeguarding, significant medical risk and urgent referral, consult the current authoritative source directly. Where current guidance conflicts with a general educational summary, the authoritative source takes priority.

Urgent escalation is required when clinical features suggest airway or swallowing compromise, rapidly spreading infection, significant uncontrolled bleeding, serious systemic involvement, suspected malignancy, important neurological change or another time-critical condition. A calculator or reference page cannot replace clinical judgement in those circumstances.

Practical checklist

• Define the clinical question.
• Confirm the history, diagnosis and relevant risk modifiers.
• Use reproducible measurements and justified investigations.
• Interpret findings in the full patient context.
• Check current authoritative guidance before acting on a threshold or medicine-related recommendation.
• Document alternatives, consent, safety-netting and review.
• Seek advice or refer when complexity or risk exceeds competence or facilities.

Quality assurance

Quality improvement should focus on reproducibility and clinically meaningful outcomes rather than simply collecting more data. Teams can agree definitions, calibrate measurement methods, review imaging and device performance where relevant, and periodically audit records for completeness. Unexpected shifts in results should be investigated before being assumed to represent true biological change.

References

The structured references attached to this DentaCalc article provide professional and methodological context. Clinicians should also consult the latest national guidance, specialty recommendations, regulatory standards and product information applicable to the patient and jurisdiction.

Focused clinical considerations

In antimicrobial stewardship in dentistry, the clinician should distinguish findings that merely describe the current presentation from findings that alter diagnosis, urgency, prognosis or treatment. This distinction helps avoid unnecessary intervention and makes the record more useful at review. Consider whether the problem is localised or generalised, stable or progressive, symptomatic or incidental, and whether previous care has changed the expected presentation. Relevant medical conditions, medicines, age, developmental stage, periodontal support, caries activity, oral hygiene, functional demands and the patient’s ability to maintain treatment may modify the plan.

Within Pharmacology, treatment thresholds should not be treated as universal cut-offs. A measurement or classification may support communication and consistency, but its meaning depends on how it was obtained and on the clinical question. Borderline findings deserve particular care: confirm technique, repeat a measurement when appropriate, compare with previous records and look for corroborating clinical evidence before making an irreversible decision.

Treatment planning in practice

Convert the assessment into a problem list and prioritise each item according to urgency, disease activity, symptoms, prognosis and patient preference. Immediate problems should be separated from disease-control needs and from elective definitive care. Where several reasonable options exist, compare expected longevity, biological cost, maintenance burden, reversibility, likely complications and the effect of delaying or declining treatment. The selected plan should be achievable for the individual patient rather than simply technically possible.

Reassessment is an active stage of care rather than an administrative endpoint. Define the response that would justify continuing the plan and the finding that would trigger modification, further investigation or referral. When treatment depends on behaviour or home care, provide specific achievable instructions and record the agreed goals. Where maintenance is essential to prognosis, explain this before definitive treatment so that long-term responsibilities are understood.

When to seek additional advice

Additional advice or referral should be considered when the diagnosis remains uncertain after appropriate assessment, pathology is atypical or progressive, expected healing does not occur, anatomical or technical complexity is substantial, important medical factors materially increase risk, or the required treatment lies outside the clinician’s training or facilities. Referral does not remove the need for appropriate interim care, communication and safety-netting while the patient is waiting.

For children, vulnerable adults and patients requiring additional support, adapt communication and consent processes to the individual. Consider capacity, parental responsibility or appropriate representatives where relevant, while still involving the patient as fully as possible. Safeguarding concerns should follow applicable professional and local procedures.

Reviewing outcomes

At follow-up, compare the outcome with the original clinical question and baseline findings. Record both objective change and the patient’s experience. Improvement in one measure does not necessarily mean that disease risk has been controlled, and lack of numerical change does not always mean treatment has failed. Interpret the pattern of findings together and revise the risk assessment when new information becomes available.

Good longitudinal records make future decisions safer. Use consistent terminology and, where practical, the same measurement method. Document important negative findings as well as positive ones when they affect the differential diagnosis or urgency. If the plan changes, record the new information or patient preference that prompted the change.